Table 4.
Odds ratios of non-alcoholic fatty liver disease compared with controls
| 1OR (95%CI) | 2OR (95%CI) | |
| All NAFLD vs all controls | ||
| Hyperlipidemia | 2.19 (1.81-2.65) | 1.37 (1.04-1.80) |
| Hypertension | 2.98 (2.37-3.74) | 1.49 (1.10-2.03) |
| Diabetes | 2.97 (2.14-4.11) | 1.68 (1.08-2.62) |
| MS | 6.29 (4.78-8.28) | 2.34 (1.65-3.31) |
| Central obesity | 6.56 (5.16-8.33) | 1.97 (1.38-2.80) |
| Lean-NAFLD vs lean controls | ||
| Hyperlipidemia | 1.87 (1.28-2.73) | 1.29 (0.80-2.09) |
| Hypertension | 3.26 (2.08-5.10) | 1.72 (1.00-2.96) |
| Diabetes | 3.87 (2.11-7.08) | 2.47 (1.14-5.35) |
| MS | 5.38 (2.66-10.89) | 3.19 (1.38-7.35) |
| Central obesity | 2.37 (1.44-3.90) | 2.17 (1.17-4.05) |
| Overweight-obese NAFLD vs overweight-obese controls | ||
| Hyperlipidemia | 1.61 (1.22-2.12) | 1.36 (0.96-1.91) |
| Hypertension | 1.64 (1.20-2.24) | 1.33 (0.92-1.93) |
| Diabetes | 1.87 (1.21-2.91) | 1.34 (0.80-2.27) |
| MS | 2.43 (1.75-3.38) | 1.89 (1.29-2.77) |
1OR: Crude OR; 2OR: Adjusted by age, sex, body mass index, smoking, alcohol consumption and physical activities. NAFLD: Non-alcoholic fatty liver disease; OR: Odds ratio; CI: Confidence interval; MS: Metabolic syndrome.